RA
OCDX

Royce & Associates’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Royce & Associates’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-449,168
Closed -$9.61M – 1033
2021
Q4 		$9.61M Sell
449,168
-253,700
-36% -$5M 0.07% 405
2021
Q3 		$13M Sell
702,868
-181,132
-20% -$3.65M 0.1% 339
2021
Q2 		$18.9M Sell
884,000
-35,000
-4% -$712K 0.13% 259
2021
Q1 		$17.7M Buy
+919,000
New +$16.2M 0.12% 287

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Royce & Associates's OCDX Position: Q1 2022 in Review

Royce & Associates sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 449,168 shares — an estimated $9.61M sold.

Royce & Associates first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $18.9M in Q2 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Royce & Associates reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Royce & Associates sold 449,168 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $9.61M.
  • Royce & Associates first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Royce & Associates's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $18.9M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.